Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.

Abstract excerpt

BACKGROUND: Cystic fibrosis is the most common inherited life-shortening illness in Caucasians and caused by a mutation in the gene that codes for the cystic fibrosis transmembrane regulator protein (CFTR), which functions as a salt transporter. This mutation most notably affects the airways of people with cystic fibrosis. Excess salt absorption by defective CFTR dehydrates the airway lining and leads to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aminophenols
• Share to Clinical Trials, Phase II as Topic